Pharmaceutical and life sciences is a highly complex industry that represents the fastest growing segment of healthcare.
We serve a broad range of clients, including the major global pharmaceutical companies; public biotechnology and speciality pharmaceutical companies; research, development and services-orientated firms that participate in the life sciences space; and smaller, highly entrepreneurial venture-backed life sciences organisations.
Our specialist consultant, Clive Sexton, combines experience in both executive search and interim management as well as relevant industry expertise in a broad range of functions. These include research, clinical development, regulatory affairs, finance, business development, marketing and sales, human resources and information technology.
Pharmaceutical companies are walking a tightrope between the need to develop new blockbuster drugs, and demand from investors for double-digit returns.
To complicate matters, soaring R&D and marketing costs are eroding profit margins. Pharmaceutical companies are having to find new ways to plug product gaps and maintain growth rates if they are to maintain long term revenue streams.
Given these challenges, today's pharmaceutical companies need leaders with broad experience, including a background in drug development, commercialisation and deal-making.
Converging disciplines and technologies are opening new frontiers in areas such as nanotechnology, genomics, proteomics, bio-defence and RNA research. A resurgence in venture capital investment, industry consolidation and the drive to fortify pharmaceutical pipelines is fuelling industry growth and the demand for experienced leaders.
Along with this increasing interconnectivity comes new challenges. Life sciences companies must innovate and reach new markets, whilst ensuring operational efficiency amid pricing pressure, decreasing reimbursement levels, and soaring R&D and marketing costs.
Companies in the medical devices and diagnostics industry are continuously working to develop products and technologies that can better diagnose and treat disease, whilst enabling less invasive and less costly procedures - all while upholding stringent industry standards for quality.
Each of these business sectors are intellectually property-intensive. The new millennium finds the life sciences industry facing a host of new challenges:
We aim to work in partnership with our clients acting as a trusted advisor, providing sound advice, clear communication, rigorous research and referencing to provide you with the assurance that you will have the right interim executive for your needs.
Email us at info@impactexecutives.com or phone on +44 (0)20 7314 2011
Tel:+44 (0) 20 7314 2011
Fax:+44 (0) 20 7314 2020